Showing results (1-10 of 68) with videos related to
Sort By:
Pageof 7
Current Topics in Medicinal Chemistry|May 29, 2003
Structure-activity relationship studies: M2 and CCR5 receptor antagonistsCraig D Boyle, Anandan PalaniCurrent Opinion in Drug Discovery & Development|July 5, 2008
Recent advances in the discovery of 11beta-HSD1 inhibitorsCraig D BoyleOrganic Letters|May 26, 2007
The total synthesis of psymberinXianhai Huang, Ning Shao, Anandan Palani, et al.Organic Letters|December 4, 2004
Manipulation of N,O-nucleophilicity: efficient formation of 4-N-substituted 2,4-dihydro-3H-1,2,4-triazolin-3-onesXianhai Huang, Anandan Palani, Dong Xiao, et al.Expert Opinion on Therapeutic Patents|May 22, 2009
11beta-hydroxysteroid dehydrogenase type 1 inhibitors: a review of recent patentsCraig D Boyle, Timothy J KowalskiOrganic Letters|February 10, 2009
The discovery of potent antitumor agent C11-deoxypsymberin/irciniastatin A: total synthesis and biology of advanced psymberin analogsXianhai Huang, Ning Shao, Robert Huryk, et al.ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of a Potent Dihydrooxadiazole Series of Non-ATP-Competitive MK2 (MAPKAPK2) InhibitorsJun Qin, Pawan Dhondi, Xianhai Huang, et al.Bioorganic & Medicinal Chemistry Letters|October 6, 2005
Biaryl diamides as potent melanin concentrating hormone receptor 1 antagonistsAnandan Palani, Sherry Shapiro, Mark D McBriar, et al.The Journal of Organic Chemistry|July 16, 2013
Ligand-dependent site-selective Suzuki cross-coupling of 3,5-dichloropyridazinesXing Dai, Yonggang Chen, Stephanie Garrell, et al.Bioorganic & Medicinal Chemistry Letters|March 18, 2004
Isopropyl amide derivatives of potent and selective muscarinic M2 receptor antagonistsAnandan Palani, Sundeep Dugar, John W Clader, et al.Pageof 7